Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fatty Liver in Covid-19: A Risk Factor or a Common Receptor? Publisher Pubmed



Anushiravani A1 ; Radmard AR2 ; Rayatpisheh M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Iranian Medicine Published:2021


Abstract

[No abstract available]
Other Related Docs
12. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
17. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
28. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
30. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
33. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
36. Covid-19: A New Horizon in Congenital Heart Diseases, Frontiers in Pediatrics (2021)
39. A Reliable Prognostic Marker for Liver Dysfunction in Covid-19 Infection, Middle East Journal of Digestive Diseases (2021)
50. Transmission Modes of Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2021)